The UL24 gene of herpes simplex virus 1 (HSV-1) is widely conserved among all subfamilies of the Herpesviridae. It is one of only four HSV-1 genes for which mutations have been mapped that confer a syncytial plaque phenotype. In a mouse model of infection, UL24-deficient viruses exhibit reduced titres, particularly in neurons, and an apparent defect in reactivation from latency. There are several highly conserved residues in UL24; however, their importance in the role of UL24 in vivo is unknown. In this study, we compared virus strains with substitution mutations corresponding to the PD-(D/E)XK endonuclease motif of UL24 (vUL24-E99A/K101A) or a substitution of another highly conserved residue (vUL24-G121A). Both mutant viruses cause the formation of syncytial plaques at 39 6C; however, we found that the viruses differed dramatically when tested in a mouse model of infection. vUL24-E99A/K101A exhibited titres in the eye that were 10-fold lower than those of the wild-type virus KOS, and titres in trigeminal ganglia (TG) that were more than 2 log 10 lower. Clinical signs were barely detectable with vUL24-E99A/K101A. Furthermore, the percentage of TG from which virus reactivated was also significantly lower for this mutant than for KOS. In contrast, vUL24-G121A behaved similarly to the wild-type virus in mice. These results are consistent with the endonuclease motif being important for the role of UL24 in vivo and also imply that the UL24 temperature-dependent syncytial plaque phenotype can be separated genetically from several in vivo phenotypes.
INTRODUCTION
The UL24 gene of herpes simplex virus 1 (HSV-1) is considered a core herpesvirus gene (Davison, 2002) . In cell culture, HSV-1 strains that do not express a functional UL24 protein exhibit a syncytial plaque phenotype (syn) (Jacobson et al., 1989; Sanders et al., 1982; Tognon et al., 1991) , particularly at elevated temperatures, and a 5-10-fold decrease in virus yield in a replication assay with one-step kinetics (Jacobson et al., 1989) . In addition to UL24, syn mutations have been mapped to gB, gK and UL20 (reviewed by Spear, 1993) ; however, the UL24 syn phenotype appears to be unique in that it is more penetrant at 39 than at 37 u C (Jacobson et al., 1989; Tognon et al., 1991) . In a mouse model of corneal infection, UL24-deficient viruses exhibit an approximate 10-fold decrease in virus titres in tear films during acute eye infection and an approximate 4 log 10 decrease in titres in trigeminal ganglia (TG), as well as a large reduction in the number of TG from which virus reactivates in an explant assay (Jacobson et al., 1998) . UL24 homologues have also been shown to be important in the pathogenesis of several other herpesviruses. HSV-2 UL24-deficient strains exhibit reduced virulence in both murine and guinea pig models of infection (Blakeney et al., 2005) . Furthermore, when the UL24 homologue in VZV, orf 35, is deleted, the virus exhibits decreased replication in T cells using a human/SCID xenograph model of infection (Ito et al., 2005) . Thus, several lines of evidence point to the importance of UL24 in the pathogenicity of herpesviruses.
The HSV-1 UL24 protein consists of 269 aa and migrates in a denaturing polyacrylamide gel with the expected molecular mass of 29.5 kDa (Pearson & Coen, 2002) . The protein is highly basic with a predicted pI of 10.86. The Nterminal region of the protein is conserved among all UL24 proteins of different herpesviruses and contains stretches of highly conserved residues termed homology domains (HDs) (Jacobson et al., 1989) . Bioinformatics studies have identified a PD-(D/E)XK endonuclease motif within the Nterminal conserved region of the protein (Knizewski et al., 2006) , the functionality of which has yet to be determined. The amino acids making up this motif are among the most highly conserved in UL24 and are located within the HDs. Transient expression of UL24 homologues from murine gammaherpesvirus 68, Kaposi's sarcoma-associated virus, IP: 54.70.40.11
On: Thu, 27 Dec 2018 22:13:32 human cytomegalovirus and HSV-1 induce a G2M cell cycle block (Nascimento & Parkhouse, 2007; Nascimento et al., 2009) . UL24 is required for the HSV-1-induced dispersal of nucleolin (Lymberopoulos & Pearson, 2007) and the N-terminal region of UL24 is sufficient to induce the redistribution of this nucleolar protein (Bertrand & Pearson, 2008) . More recently, we found that residues corresponding to the putative catalytic domain are especially important for the ability of UL24 to induce this modification of nucleoli. The residue G121, which is not predicted to be part of the endonuclease motif, and residues E99 and K101, which are part of the motif, are each conserved with 100 % identity among the sequences deposited in GenBank for UL24 and its homologues from 78 different herpesviruses. When introduced into the virus genome, the mutations G121A and E99A/K101A both result in a syn phenotype at 39 u C, but differ with regards to their impact on nucleoli and virus yield (Bertrand et al., 2010) . The contribution of different conserved residues to the role of UL24 in a mammalian host is not known.
We hypothesized that there is a functional link between the phenotypes of UL24 mutants observed in cell culture and the impact of the mutations on pathogenesis. To test this hypothesis, we studied recombinant HSV-1 strains harbouring mutations corresponding to single or double amino acid substitutions of highly conserved residues in UL24 that we have previously characterized in cell culture. In this study, the impact of the mutations in vivo and in an ex vivo reactivation assay was tested using the wellestablished mouse model of ocular infection.
RESULTS
In cell culture, vUL24-E99A/K101A behaves similarly to a UL24-null virus in that it is deficient in the virus-induced dispersal of nucleolin and the virus yield is 5-10-fold lower than for the wild-type virus KOS in an assay with one-step replication kinetics. In contrast, vUL24-G121A exhibits only a moderate defect in the dispersal of nucleolin and appears to replicate as efficiently as KOS in cell culture (Bertrand et al., 2010) ; however, both viruses form syncytial plaques at 39 u C. In the present study, these viruses were evaluated in a well-established murine model of ocular infection Leib et al., 1989) to determine the impact of these mutations in vivo.
vUL24-E99A/K101A and vUL24-G121A retain thymidine kinase (TK) expression
In the HSV-1 genome, the UL24 and thymidine kinase (tk) genes partially overlap at their 59 ends and are transcribed divergently. As such, mutations targeting the promoter region or within the first 22 codons of one gene can affect the other gene. Because a functional TK enzyme is required for virus reactivation (Chen et al., 2004; Coen et al., 1989) , we selected two UL24 mutations for our in vivo studies that fall outside of the TK open reading frame (ORF), namely E99A/K101A and G121A. Previous promoter analyses for tk suggest that mutations in these regions should not inhibit TK expression (Coen et al., 1986) . Furthermore, sequencing to check the mutated versions of UL24 in the viruses also served to establish that no mutations other than the ones due to the intended codon change in UL24 were present in the tk promoter. In order to confirm that TK expression was retained with these viruses, Vero cells were either mock-infected or infected at an m.o.i. of 10 and total cell lysates were harvested at 6 h post-infection (p.i.). Western blot analyses revealed that TK expression was retained for both independently derived isolates of vUL24-E99A/K101A and vUL24-G121A (Fig. 1) .
In vivo characterization of vUL24-eGFPb and vUL24-eGFPbRescue
The vUL24-E99A/K101A and vUL24-G121A recombinant strains were derived from vUL24-eGFPb. In vUL24-eGFPb, an expression cassette of 1405 bp containing a cytomegalovirus promoter driving transcription of the gene for the enhanced green fluorescent protein (eGFP) has been inserted such that it disrupts UL24 (Bertrand et al., 2010) . This virus also expresses approximately 10-fold less TK (data not shown) because the eGFP insertion falls within the tk promoter. By using this starting virus, we were able to screen easily for recombinants through loss of eGFP. In cell culture, vUL24-eGFPb exhibits between a 5-and 10-fold decrease in virus yield in a replication assay with one-step kinetics compared with the wild-type strain KOS, whereas the corresponding repaired virus (vUL24-eGFPbRescue) replicates as efficiently as KOS (Bertrand et al., 2010) . To determine whether vUL24-eGFPb harboured mutations outside UL24 that could, in and of themselves, confer in vivo defects in our assays and thus confound the interpretation of the results for our substitution mutants, we tested both it and vUL24-eGFPbRescue in a mouse model of ocular infection. Results presented represent the pooled data from two independent experiments (Fig. 2) . We found that, in the eye, titres of vUL24-eGFPb were approximately 10-fold lower than KOS titres (Fig. 2a) . Importantly, this defect was corrected in the case of vUL24-eGFPbRescue, which replicated to similar levels to KOS. Similarly, we found that the insertion of the eGFP expression cassette in UL24 caused on average a .3 log 10 decrease in virus titres in neurons 3 days p.i., which was corrected with the rescue virus (Fig. 2b) . Furthermore, although only 20 % of TG from mice infected with vUL24-eGFPb scored positive for reactivation, there was no statistical difference in the number of TG from which virus reactivated upon explant when comparing vUL24-eGFPbRescue (90 %) and KOS (95 %) ( Table 1 , top section). Thus, we found that vUL24-eGFPb behaved like the UL24-deficient virus UL24X (Jacobson et al., 1998) , which was expected because the UL24 gene is disrupted. Importantly, vUL24-eGFPbRescue behaved like KOS in our in vivo assays. We cannot rule out the possibility that the starting virus contains a mutation which, in combination with a mutation in UL24, results in a phenotype not observed with the latter mutation alone; however, these results indicated that vUL24-eGFPb did not contain any mutations aside from the eGFP insertion in UL24 that, in and of themselves, diminished its ability to replicate in vivo or to reactivate in an explant assay.
Effect of UL24 substitutions on virus titres in the eye
In order to determine the effect of the different UL24 mutations in mice, both independent isolates of vUL24-G121A and vUL24-E99A/K101A were tested. Results shown represent the pooled data from seven experiments. In each experiment, the substitution viruses were tested in parallel with the control viruses KOS and tkLTRZ-1 (Davar et al., 1994) , which lacks a functional tk gene and served as a negative control for virus reactivation. Each virus (i.e. each isolate) was tested in at least two independent experiments. We titrated virus present in the tear films of mice 1, 2 and 3 days p.i. (Fig. 3a-c) . At 1 day p.i., the means of the titres for each isolate of vUL24-E99A/K101A were lower than for KOS, although there was no statistically significant difference. As infection progressed, this trend continued: at both 2 and 3 days p.i., there was a statistically significant decrease in titres for vUL24-E99A/ K101A compared with KOS of between 5-and 10-fold. In contrast, there was no statistically significant difference in Top section: vUL24-eGFPb and its corresponding rescue virus were tested in an ex vivo reactivation assay in parallel with the wild-type virus KOS. Results presented are the pooled data from two independent experiments. Bottom section: vUL24-E99A/K101A-a and -b, and vUL24-G121A-a and -b were tested in an ex vivo reactivation assay in parallel with KOS and tkLTRZ-1, which was included as a negative control for reactivation. Results shown represent the pooled data from six experiments. TG were harvested between 30 and 40 days p.i. and each were independently dissociated and overlaid on a monolayer of Vero cells. Plates were monitored for 10 days for the appearance of cytopathic effects.
Virus
No. reactivated TG/total TG (%)* the levels of replication in the eye observed for vUL24-G121A and KOS at any of the time points tested. Differential importance of highly conserved UL24 residues for acute infection in neurons, reactivation and disease UL24 is known to be particularly important for HSV-1 neuronal infection in vivo. We found a striking difference between the impact of the E99A/K101A and G121A mutations on virus titres in TG at 3 days p.i. (Fig. 3d) . vUL24-E99A/K101A exhibited a statistically significant 2 log 10 or greater decrease in neuronal titres, whilst, in contrast, vUL24-G121A replicated to levels similar to KOS. We next tested the impact of each mutation in a standard explant reactivation assay (Table 1 , bottom section). Data presented were pooled from mice infected in the context of six of the seven experiments shown in Fig. 3 . Similar to the results for virus titres in TG, we found that the E99A/K101A mutation caused a statistically significant decrease in the number of TG from which virus reactivated as compared with KOS (26 and 41 % for each isolate as opposed to 100 % for KOS). In contrast, we detected reactivation in 94 and 97 % of TG corresponding to vUL24-G121A-a and -b, which was not statistically significantly different from the results for KOS.
During our in vivo studies, we noticed a dramatic difference in the ability of the mutant viruses to cause disease. To assess systematically the impact of the UL24 mutations on disease, we infected mice in parallel with KOS, the UL24-deficient virus UL24XG (Jacobson et al., 1998) , tkLTRZ-1, vUL24-E99A/K101A-a and -b and vUL24-G121A-a and -b, and scored for the severity of disease by daily visual inspection for 11 days p.i. For each virus tested, five mice were infected, with the mean score shown for each day (Fig. 4) . Similar to what has been observed previously [for example, by Davido & Leib (1996) ], in KOS-infected animals we detected inflammation around the eyes and face starting at 4 days p.i., following which there was some hair loss in the face and head area and often development of lesions. Less commonly, we also observed neurological symptoms such as ataxia. UL24XG rarely caused detectable disease, and even in those cases where it did so, only mild inflammation was detected. vUL24-E99A/K101A behaved similarly to UL24XG, and thus, even though titres in the tear films for these viruses are only reduced by approximately 10-fold compared with KOS, they were highly attenuated. These results are consistent with a previous report suggesting that levels of replication in the eye of strain McKrae did not correlate with eye disease (Mott et al., 2009) , although in Fig. 3 . Impact of substitution mutations in UL24 on acute infection in mice. Each independent isolate of vUL24-E99A/K101A (m, isolate a; ., isolate b) and vUL24-G121A (g, isolate a; h, isolate b) was tested in vivo in at least two independent experiments. Data shown were pooled from seven independent experiments. KOS ({) and tkLTRZ-1 (L) were control viruses. Titres of virus present in the tear films of mice at 1 (a), 2 (b) and 3 (c) days p.i. (d) Titres of virus present in TG of mice harvested at 3 days p.i. P values were obtained using the one-sided analysis of variance, a50.05. The detection thresholds are represented by the dashed lines.
this report wild-type strains were used. Interestingly, even though vUL24-G121A also exhibited a syn phenotype in cell culture, it caused disease of a similar severity to that observed with KOS. In other experiments, we found that vUL24-eGFPb, the starting virus for construction of our substitution mutants, was attenuated similarly to UL24XG. In contrast, vUL24-eGFPbRescue caused disease similar to KOS, once again confirming the wild-type phenotype of this virus (data not shown). Thus, there appeared to be a major difference in the pathogenicity of vUL24-E99A/ K101A and vUL24-G121A; however, major defects in pathogenesis did not appear to correlate with the UL24 syn phenotype.
vUL24-G121A retains a syn phenotype upon passage in mouse TG Our in vivo results suggested that, even though vUL24-G121A forms syncytial plaques, it replicates like the wildtype virus in vivo and causes disease. However, another possibility was that genetic pressure in the TG selected for a reversion or compensatory event such that the virus that succeeded in replicating in neurons had lost the syn phenotype. To test for this possibility, the UL24 gene from virus present in the TG at 3 days p.i. was amplified from three mice infected with vUL24-G121A and sequenced. We found that the G121A mutation was still present in virus isolated from each of the mice and no other mutation in the UL24 ORF was detected. We next ruled out the possibility that an extragenic compensatory mutation may have arisen during passage through mice that reversed the syn phenotype. Virus from TG 3 days p.i. was used to infect Vero cells, which were then incubated under methylcellulose at either 37 or 39 u C for 2 days (Fig. 5) . We observed the characteristic temperature-enhanced syn phenotype for each of the vUL24-G121A independent isolates, but not for KOS. Thus, the syn phenotype caused by the G121A mutation was retained upon passage in mice. We concluded that the UL24-associated syn phenotype seen at 39 u C can be dissociated genetically from several UL24-associated phenotypes in vivo.
DISCUSSION
Mutations in the UL24 gene of HSV-1 are associated with several phenotypes both in cell culture and in animals. The syn phenotype is particularly striking in that a similar phenotype is observed with mutations mapping to only three other genes in HSV-1. Because there are many important fusion events during the life cycle of HSV-1 replication, we hypothesized that the apparent fusion modulatory function of UL24 is important for virus pathogenesis. Interestingly, we discovered a relatively conservative substitution, G121A, that induced a pronounced syn phenotype at 39 u C, but also retained wildtype pathogenicity in a mouse model of ocular infection. Therefore, whilst it may be that a less conservative substitution would have a greater effect on pathogenesis, it remains that the syn phenotype caused by the G121A mutation did not lead to a statistically measurable difference in replication in mice or in reactivation in an explant assay. We cannot rule out the possibility that the G121A mutation affects aspects of pathogenicity that are not measured by the assays used in our study. For example, it is possible that the G121A mutation would have an impact in an in vivo reactivation assay. However, our results do allow us to conclude that the temperaturesensitive syn phenotype associated with UL24 can be dissociated from several in vivo phenotypes related to this gene. Other HSV-1 genes associated with syn phenotypes are gB, UL20 and gK. gB is involved in entry and egress, both processes that involve fusion (Calistri et al., 2007; Wright et al., 2009; reviewed by Spear & Longnecker, 2003) . UL20 and gK are involved in secondary envelopment of virions (Baines et al., 1991; Foster & Kousoulas, 1999; Fuchs et al., 1997; Hutchinson & Johnson, 1995; Jayachandra et al., 1997) . It has been shown that UL20 is required for the correct trafficking and localization of gK (Foster et al., 2003) . In addition, a UL20-null mutation can suppress fusion in the context of infection with a virus carrying a syn mutation in gK or gB (Foster et al., 2004) . Likewise, gK is required for syncytium formation caused by gB (Melancon et al., 2005) and UL20 syn mutations. The mechanisms underlying the link between UL24 and fusion are not known. Thus, the G121A mutant may serve as a useful tool to look specifically at UL24 defects in fusion modulation in the context of wild-type levels of replication.
In contrast to our results for G121A, we found that the E99A/K101A mutation caused a significant decrease in virus titres in vivo, particularly in TG, and resulted in Importance of conserved UL24 residues in pathogenesis significantly lower numbers of reactivating TG. This phenotype is very similar to the phenotype of the UL24-null virus UL24X (Jacobson et al., 1998) , suggesting that this mutation targets a critical function of the protein. Our data do not allow us to distinguish between decreased virus spread from the eye to TG, and reduced replication in neurons. Furthermore, TG from mice infected with UL24X contain approximately 2 log 10 fewer copies of the virus genome than do mice latently infected with the corresponding wild-type virus (Jacobson et al., 1998) . Thus, it will also be of interest to determine whether the E99A/K101A mutation is associated with an intrinsic defect in reactivation as opposed to a decrease in the establishment of latency, or both. Interestingly, in addition to forming syncytial plaques, vUL24-E99A/K101A is severely impaired in its ability to disperse nucleolin (Bertrand et al., 2010) , whilst the G121A mutation causes only a modest defect in this function. These results may reflect a link between the ability of the virus to modify nucleoli and pathogenicity; however, more mutations must be tested to validate this hypothesis. Similarly, although the E99A/ K101A mutation targets what would be the catalytic site of the putative endonuclease domain, a more extensive mutational analysis is required to determine whether this potential activity is important for pathogenesis.
METHODS
Viruses and cells. HSV-1 strains were propagated and titrated on Vero cells as described previously (Lymberopoulos & Pearson, 2007) . The HSV-1 strains KOS, UL24XG (Jacobson et al., 1998) and tkLTRZ-1 (Davar et al., 1994) were originally provided by D. M. Coen (Harvard Medical School, Boston, MA, USA). vUL24-eGFPb, vUL24-eGFPbRescue, vUL24-E99A/K101A-a and -b and vUL24-G121A-a and -b are described elsewhere (Bertrand et al., 2010) . Briefly, to make vUL24-eGFPb, KOS-infectious DNA was co-transfected with the linearized transfer vector pBamHIQeGFP; to make the rescue virus, vUL24-eGFPb infectious DNA was co-transfected with the linearized vector pAG5 (Griffiths & Coen, 2003) ; and to make the substitution mutants, vUL24-eGFPb infectious DNA was co-transfected with either the linearized vector pKOS-UL24-E99A/K101A or pKOS-UL24-G121A. Each of the transfer vectors contains the BamHI Q fragment of the KOS genome in the plasmid pSK+. Strains a and b represent independently derived isolates of the indicated virus. Each independent isolate is the result of an independent transfection of infectious virus DNA and the corresponding transfer vector.
Western blotting. Western blotting was carried out essentially as described previously (Pearson & Coen, 2002) . Vero cells were infected at an m.o.i. of 10 and cell lysates were harvested 6 h p.i. The following antibodies were used: rabbit antiserum raised against TK (W. Summers, Yale University, New Haven, CT, USA), mouse anti-ICP8 (Chemicon), goat anti-mouse horseradish peroxidase conjugated IgG (Jackson ImmunoResearch Laboratories), goat anti-rabbit peroxidase conjugated IgG (Bethyl Laboratories).
Murine model of ocular infection. All animal experiments were carried out at the INRS Centre for Experimental Biology in accordance with institutional good animal care practices. Mouse experiments were conducted essentially as described previously Leib et al., 1989) . Seven-week-old CD-1 mice (Charles River) were acclimatized for 5-7 days prior to infection. For infections, mice were first deeply anaesthetized by intraperitoneal injection of a solution of ketamine (100 mg kg 21 ; Bioniche) and xylazine (10 mg kg 21 ; Bayer) diluted in saline. Following light scarification of the cornea, 2610 6 p.f.u. of virus were applied in a dropwise manner in a volume of 7-10 ml to each cornea of the mice. Groups of at least five animals per virus were infected in each individual experiment, with the exception of two experiments where only four animals were infected for a control virus. The control viruses KOS and tkLTRZ-1 were included in each experiment except for experiment number seven from which no reactivation data were collected, and thus tkLTRZ-1 was not included. Virus titres during acute eye infection were determined from 1 to 3 days p.i. by titrating virus in pooled tear films from both eyes collected with moistened sterile cotton swabs while the mice were anaesthetized with isoflurane (Baxter). Titres of virus in TG during acute infection were determined by titrating virus present in the pooled homogenates of both TG harvested post-mortem at 3 days p.i. For titres in the eye, on each day in question (i.e. 1, 2 and 3 days p.i.) eye swabs were taken from three mice per virus. For titres in TG, TG were harvested from three mice for each virus per experiment. Data points that were below the level of detection of the assay were treated as the limit values for calculation of means. Virus reactivation was assessed using an explant assay 30-40 days p.i. For the reactivation assays, individual TG were dissociated with collagenase (Invitrogen) and overlaid on a monolayer of Vero cells. Reactivation for each TG was determined by the appearance of the virus-induced cytopathic effect of the Vero cells, which was monitored for 10 days post-explant.
Disease scoring. Acute disease was assessed visually and scored on a scale of 0-4 based on levels of inflammation, presence and extent of hair loss, and the presence and extent of visible skin lesions. Five animals per group were followed daily for the indicated period of time.
Sequencing. Templates for DNA sequencing of UL24 in viruses were generated by PCR using the primers 59-TACGTAGACGATA-TCGTCGCGCGA and 59-GATCCAAATGAGTCTTCGGACCTCGC (Integrated DNA Technologies). Sequencing was carried out by the McGill University and Genome Quebec Innovation Centre.
